Physician profile
David J Spurlock
NPI 1700914348
$7,484.08
in general payments reported to CMS, 2019-2025
9 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.63 · 2020: $1,730 · 2021: $986 · 2022: $1,106 · 2023: $2,382 · 2024: $347 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430 · Travel and Lodging: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.50 |
| Travel and Lodging | $1,149.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $5,163.87 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $795.48 | 2021-2025 | Corevalve Evolut R, Evera Mri Xt Dr Surescan |
| Edwards Lifesciences Corporation | $690.20 | 2022-2023 | Konect Resilia |
| Abiomed | $345.83 | 2023-2024 | Impella |
| Teleflex LLC | $183.49 | 2025 | Manta |
| Stryker Corporation | $146.01 | 2023 | Na, Stryker Varispeed |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.42 | 2025 | Lifevest |
| Angiodynamics, INC. | $48.36 | 2022 | |
| Baxter Healthcare | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spurlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.